Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
                14%
                                OVERLAP
BY WEIGHT
10
                                # OF OVERLAPPING
HOLDINGS
JSML
                            115
                                HOLDINGS
                            
                                    5%
                                
                                ALSO IN PSCH
                            PSCH
                            69
                                HOLDINGS
                            
                                    14%
                                
                                ALSO IN JSML
                            SECTOR DRIFT (JSML minus PSCH)
                OVERLAPPING HOLDINGS
                Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in JSML  | 
                                Weight in PSCH  | 
                                Overlap | |
|---|---|---|---|---|
| CORCEPT THERAPEUTICS INC | 4.3% | 5.2% | 4.3% | |
| CATALYST PHARMACEUTICAL PART | 2.5% | 1.5% | 1.5% | |
| CORVEL CORP | 2.5% | 1.4% | 1.4% | |
| ADDUS HOMECARE CORP | 2.1% | 1.3% | 1.3% | |
| LEMAITRE VASCULAR INC | 2.3% | 1.1% | 1.1% | |
JSML Overweight Relative to PSCH
                | PRIMORIS SERVICES CORP | 3.0% | |
| OSI SYSTEMS INC | 2.6% | |
| SYMBOTIC, INC. CLASS A | 2.4% | |
| RUSH ENTERPRISES INC-CL A | 2.2% | |
| FRANKLIN ELECTRIC CO INC | 2.2% | |
| GMS INC. | 2.1% | |
| PACS GROUP INC | 2.1% | |
| MUELLER WATER PRODUCTS INC-A | 2.0% | |
| DIGITALOCEAN HOLDINGS, INC. | 2.0% | |
| PENSKE AUTO GROUP INC | 1.9% | 
JSML Underweight Relative to PSCH
                | TELEFLEX INC | -3.6% | |
| RADNET INC | -3.4% | |
| ALKERMES PLC | -3.2% | |
| GLAUKOS CORP | -3.1% | |
| ARROWHEAD PHARMACEUTICALS, INC. | -3.1% | |
| MERIT MEDICAL SYSTEMS INC | -3.1% | |
| TG THERAPEUTICS INC | -3.1% | |
| KRYSTAL BIOTECH, INC. | -2.9% | |
| TRANSMEDICS GROUP, INC. | -2.5% | |
| PROTAGONIST THERAPEUTICS, INC. | -2.4% |